Search Within

Piro Lito

Formats
  1. Journal Article (33)
  2. Meeting Abstract (16)
  3. Editorial (8)
  4. Review (1)
Groups
  1. Department of Medicine (58)
  2. GSK Faculty (58)
  3. Human Oncology and Pathogenesis Program (58)
  4. Solid Tumor Oncology Division (58)
  5. Thoracic Oncology (58)
  6. Sloan Kettering Institute Postdocs (28)

More Groups

People
  1. Gregory Riely (20)
  2. Bob Li (17)
  3. Kathryn Arbour (17)
  4. Neal Rosen (14)
  5. Charles Rudin (13)
  6. Yaohua Xue (13)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (8)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer Research (7)
  3. Clinical Cancer Research (6)
  4. Nature (5)
  5. Cancer Cell (4)
  6. Nature Medicine (4)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Nature Publishing Group (11)
  3. American Society of Clinical Oncology (9)
  4. Cell Press (7)
  5. American Association for the Advancement of Science (4)
  6. Massachusetts Medical Society (3)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid non-uniform adaptation to conformation-specific KRAS G12C inhibition
    Meeting Abstract

    Xue, J.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Adaptive resistance to dual BRAF/MEK inhibition in BRAF-driven tumors through autocrine FGFR pathway activation
    Journal Article

    Wang, V. E.; Xue, J. Y.; Frederick, D. T.; Cao, Y.; Lin, E.; Wilson, C.; Urisman, A.; Carbone, D. P.; Flaherty, K. T.; Bernards, R.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A treatment strategy for KRAS-driven tumors
    Journal Article

    Mai, T. T.; Lito, P.
    Nature Medicine (2018)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer
    Journal Article

    Xue, Y.; Martelotto, L.; Baslan, T.; Vides, A.; Solomon, M.; Mai, T. T.; Chaudhary, N.; Riely, G. J.; Li, B. T.; Scott, K.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Predicting MEK inhibitor response in lung cancer: A proper signature is required
    Journal Article

    Xue, Y.; Lito, P.
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the lung: Clinico-pathologic features, treatment, and outcomes
    Journal Article

    Naidoo, J.; Santos-Zabala, M. L.; Iyriboz, T.; Woo, K. M.; Sima, C. S.; Fiore, J. J.; Kris, M. G.; Riely, G. J.; Lito, P.; Iqbal, A.; more...
    Clinical Lung Cancer (2016)

    Fulltext@MSK | Save
  • Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Journal Article

    Lito, P.; Solomon, M.; Li, L. S.; Hansen, R.; Rosen, N.
    Science (2016)

    Fulltext@MSK | Save
  • Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors
    Meeting Abstract

    Lito, P.; Saborowski, A.; Yue, J.; Solomon, M.; Joseph, E.; Fellman, C.; Ohara, K.; Morikami, K.; Miura, T.; Lucas, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save